• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - CORK ROTALINK¿ PLUS; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - CORK ROTALINK¿ PLUS; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Model Number H749236310030
Device Problem Material Perforation (2205)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/29/2015
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Device evaluated by mfr: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that perforated sheath was noted.Vascular access was obtained via the femoral artery.The 70% stenosed, 70x2.5mm, eccentric, de novo target lesion containing a lesion bend of <=45 degrees was located in the moderately tortuous and severely calcified left anterior descending (lad) artery.The target lesion was pre-dilated with a 2.5x10mm non-bsc balloon catheter.A 1.50 mm rotalink plus was selected for treatment.A non-bsc guidewire was first to cross the lesion and was then exchanged with a rotawire through a microcatheter and inserted the rotalink burr proximal to the target lesion; however, the console stalled.The physician then attempted to conduct rotablation a couple of times; however, the same issue occurred.Upon removal of the device, a small perforation on the catheter was noted.The physician then removed the device completely from the patient's body and completed the procedure with a 32 x 2.50mm promus premier stent deployed distally to lad.A non-bsc stent was also deployed proximally to the target lesion and the thrombolysis in myocardial infarction flow (timi) of 3 was established.There were no patient complications reported and the patient status was good.
 
Manufacturer Narrative
Device evaluated by mfr.: device returned for analysis.A visual examination of the complaint unit was carried out.The handshake connection was inspected and no issue was noted.Handshake connection test was attempted but no issues were noted.The drive shaft, coil and sheath were inspected and there was no damage noted.The unit was connected to a saline infusion, no issues were noted.The complaint unit was functionally tested.The complaint unit did not reach any speed.The complaint advancer was dismantled and the ultem was found to be melted.A melted ultem is due to the interruption of saline or by insufficient flow of saline used during the preparation of the device.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause has been determined to be use/user error as reason why complaint is identified as user error and the dfu states: never operate the rotablator advancer without saline infusion.Flowing saline is essential for cooling and lubricating the working parts of the advancer.Operation of the advancer without proper saline infusion may result in permanent damage to the advancer¿.(b)(4).
 
Event Description
It was reported that perforated sheath was noted.Vascular access was obtained via the femoral artery.The 70% stenosed, 70x2.5mm, eccentric, de novo target lesion containing a lesion bend of <=45 degrees was located in the moderately tortuous and severely calcified left anterior descending (lad) artery.The target lesion was pre-dilated with a 2.5x10mm non-bsc balloon catheter.A 1.50 mm rotalink plus was selected for treatment.A non-bsc guidewire was first to cross the lesion and was then exchanged with a rotawire through a microcatheter and inserted the rotalink burr proximal to the target lesion; however, the console stalled.The physician then attempted to conduct rotablation a couple of times; however, the same issue occurred.Upon removal of the device, a small perforation on the catheter was noted.The physician then removed the device completely from the patient's body and completed the procedure with a 32 x 2.50mm promus premier stent deployed distally to lad.A non-bsc stent was also deployed proximally to the target lesion and the thrombolysis in myocardial infarction flow (timi) of 3 was established.There were no patient complications reported and the patient status was good.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTALINK¿ PLUS
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC - CORK
business and technology park
model farm road
cork
EI 
Manufacturer (Section G)
BOSTON SCIENTIFIC - CORK
business and technology park
model farm road
cork
EI  
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5323710
MDR Text Key34267651
Report Number2134265-2015-09268
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2017
Device Model NumberH749236310030
Device Catalogue Number23631-003
Device Lot Number0017986267
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/16/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/05/2015
Initial Date FDA Received12/23/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/03/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/20/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age65 YR
Patient Weight60
-
-